4//SEC Filing
DAVIS JOHN C. JR 4
Accession 0000899243-20-004321
CIK 0001690585other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 5:19 PM ET
Size
5.4 KB
Accession
0000899243-20-004321
Insider Transaction Report
Form 4
DAVIS JOHN C. JR
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-02-10+104,000→ 104,000 totalExercise: $12.28Exp: 2030-02-09→ Common Stock (104,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable in 16 equal quarterly installments beginning on January 1, 2020.
Documents
Issuer
Magenta Therapeutics, Inc.
CIK 0001690585
Entity typeother
Related Parties
1- filerCIK 0001741287
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 5:19 PM ET
- Size
- 5.4 KB